REG - EMIS Group PLC - Admission of Shares

EMISAnnouncement

24/10/2023 10:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231024:nRSX1178Ra&default-theme=true

RNS Number : 1178R  EMIS Group PLC  24 October 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE
A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

24 October 2023

EMIS GROUP PLC

("EMIS" OR THE "cOMPANY")

ADMISSION OF SHARES

On 17 June 2022, the Boards of Bordeaux UK Holdings II Limited ("Bidco") (an
affiliate of Optum Health Solutions (UK) Limited) and EMIS announced that they
had reached agreement on the terms of a recommended all cash offer pursuant to
which Bidco will acquire the entire issued and to be issued ordinary share
capital of EMIS (the "Acquisition").  The Acquisition is being implemented by
means of a Court-sanctioned scheme of arrangement under Part 26 of the
Companies Act 2006 (the "Scheme").

 

In connection with the Acquisition, and to satisfy awards held by employees of
EMIS and its subsidiaries under the Company's established share option plans,
which awards will vest and become exercisable upon Court sanction of the
Scheme, EMIS announces that it has applied for 846,034 ordinary shares of
£0.01 each in the capital of EMIS to be admitted to trading on AIM
("Admission").

 

Admission is expected to take place at 8.00 a.m. on 25 October 2023.

 

Enquiries:

 EMIS
 Andy Thorburn, Chief Executive Officer                                     +44 (0) 330 024 1269
 Peter Southby, Chief Financial Officer

 Numis (Financial adviser, corporate broker and nominated adviser to EMIS)
 Simon Willis                                                               +44 (0) 207 260 1000
 Joshua Hughes
 Havish Patel

 MHP (PR adviser to EMIS)                                                   +44 (0) 203 128 8572
 Reg Hoare                                                                  EMIS@mhpgroup.com
 Ollie Hoare
 Matthew Taylor

 Bidco / Optum UK
 Aisling Kearney                                                            +44 7971 428266

 Robey Warshaw (Financial Adviser to UnitedHealth Group and Bidco)
 Simon Warshaw                                                              +44 20 7317 3900
 Philip Apostolides

 FGS Global (PR Adviser to Bidco and Optum UK)
 John Gray                                                                  +44 20 7251 3801
 Amanda Healy                                                               Optum-LON@fgsglobal.com

 

Travers Smith LLP are retained as legal adviser to EMIS and Slaughter and May
are retained as legal adviser to Bidco and UnitedHealth Group.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEFIFIAIFLSFIV